Brain Tumors 2020: From Biology to Therapy
| DAY 1 Monday, 22 June 2020 | ||
| 11:00 - 13:00 | Registration and welcome coffee | |
| 13:00 - 14:00 | Keynote lecture: John de Groot, MD Anderson Cancer Center, USA Tbc |
|
| 14:00 - 17:20 | Brain tumor pathobiology (chairs: Dolores Hambardzumyan, Bozena Kaminska) | |
| 14:00 - 14:35 | Constantinos G. Hadjipanayis, Mount Sinai Hospital, USA Fluorescence-guided surgery and photodynamic therapy of brain tumors: a new combination |
|
| 14:35 - 15:10 | Kenneth Aldape, National Cancer Institute, USA Tbc |
|
| 15:10 - 15:40 | COFFEE BREAK | |
| 15:40 - 16:15 | Oren Becher, Northwestern University, USA Cellular heterogeneity in diffuse midline gliomas |
|
| 16:15 - 16:50 | Jacek Majewski, McGill University, Canada Epigenomic landscapes of H3K27M mutant gliomas |
|
| 16:50 - 17:20 | Oral presentations(3x10 min) | |
| 17:20 - 18:50 | Poster session part I | |
| 19:00 - 21:00 | WELCOME RECEPTION | |
| DAY 2 Tuesday, 23 June 2020 | ||
| 09:00 - 12:25 | Glioma microenvironment, immunology and immunotherapy I (chairs: Christel Herold-Mende, Aleksandra Ellert-Miklaszewska) |
|
| 09:00 - 09:35 | Bozena Kaminska, Nencki Institute, Warsaw, Poland Immune microenvironment of glioma at single cell resolution |
|
| 09:35 - 10:10 | Dolores Hambardzumyan, Emory University, School of Medicine, Atlanta, USA Glioblastoma subtype-specific heterogeneity of the immune microenvironment |
|
| 10:10 - 10:40 | COFFEE BREAK | |
| 10:40 - 11:15 | Katrin Lamszus,Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Cancer immunoediting in malignant glioma - interactions between immune cells and tumor cells |
|
| 11:15 - 11:50 | Neta Erez, Tel Aviv University, Israel Astrocyte-mediated neuroinflammation facilitates melanoma brain metastasis |
|
| 11:50 - 12:25 | Christel Herold-Mende, University of Heidelberg, Germany Molecular determinants of immune cell infiltration in brain tumors |
|
| 12:25 - 13:25 | LUNCH BREAK |
|
| 13:25 - 18:00 | Glioma microenvironment, immunology and immunotherapy II (chairs: Dinorah Friedman-Morvinski, Wiesława Grajkowska) |
|
| 13:25 - 14:00 | Martin van den Bent, Erasmus MC Cancer Institute Rotterdam Netherlands Tbc |
|
| 14:00 - 14:35 | Anna Kenney, Winship Cancer Institute, Emory University, USA Radiation resistance in the medulloblastoma perivascular niche |
|
| 14:35 - 15:10 | Dieter Henrik Heiland, University of Freiburg, Germany The role of glial microenvironment in the dysregulation of immune surveillance of brain tumors |
|
| 15:10 - 15:35 | COFFEE BREAK | |
| 15:35 - 16:10 | Dinorah Friedmann-Morvinski, Tel Aviv University, Israel Adoptive T-cell immunotherapy with potential dual function for the treatment of glioblastoma |
|
| 16:10 - 16:45 | Waldemar Debinski, Wake Forest School of Medicine, USA Markers of Macrophage Activation in Glioblastoma |
|
| 16:45 - 17:20 | Alessandro Michelucci, Neuro-Immunology Group, Department of Oncology, Luxembourg Institute of Health, Luxembourg Revealing and harnessing tumour-associated microglia/macrophage heterogeneity in glioblastoma |
|
| 17:20 - 17:40 | Advanced in single cell omics (10X Genomics) | |
| 17:40 - 18:10 | Oral presentations (3x10 min) | |
| 18:10 - 19:30 | Poster session part II | |
| 20:00 - 23:00 | Gala dinner (by invitation) | |
| DAY 3 Wednesday, 24 June 2020 | ||
| 09:00 - 16:00 | Brain tumor pathobiology, diagnostics & therapy (chairs: Tika Benveniste, Sergiusz Nawrocki) | |
| 09:00 - 09:35 | Itay Tirosh, Weizmann Institute of Science, Israel Dissecting intra-tumor and inter-tumor heterogeneity in glioma |
|
| 09:35 - 10:10 | Agnieszka Bronisz, Harvard Medical School/Mossakowski Medical Institute, Poland Targeting hypoxia response for oncolytic virus immunotherapy |
|
| 10:10 - 10:40 | COFFEE BREAK | |
| 10:40 - 11:15 | Guido Reifenberger, University of Dusseldorf, Germany Tbc |
|
| 11:15 - 11:50 |
|
|
| 11:50 - 12:25 | Maria G. Castro, University of Michigan, USA Epigenetic reprogramming of the tumor immune microenvironment in mutant IDH1 gliomas mediated myeloid cell populations and reverses immunosuppression |
|
| 12:25 - 13:25 | LUNCH | |
| 13:25 - 14:00 | Maciej Wiznerowicz, International Institute for Molecular Oncology, Poland Cancer Stemness as Hallmark of Oncogenic De-differentiation |
|
| 14:00 - 14:35 | Houtan Noushmehr, Henry Ford Cancer Institute, USA Advances in Epigenomic Classification and Liquid Biopsy in Glioma |
|
| 14:35 - 15:10 | Petra Hamerlik, Danish Cancer Society Research Center, Denmark Functional interplay between aberrant DNA repair and cellular hierarchies in glioblastoma |
|
| 15:10 - 15:45 | Waldemar Priebe, MD Anderson Cancer Center, University of Texas, Houston, USA Drug Discovery in Academia: Focus on CNS Malignancies |
|
| 15:45 - 16:00 | Closing remarks | |
| 16:00 - 19:00 |
Guided tour: Warsaw sightseeing (optional, free of charge) | |
 |
||